Form D · Pharmaceuticals
SciSparc Ltd.
Tel Aviv, L3 · CIK 0001611746
Offering snapshot reported Mar 3, 2025 · SEC filing
- Reported sold
- $4.2M Offering amount: $4.2M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 25, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 3, 2025 | Initial | $4,200,000 | No comparison | 4 | SEC filing |
| Oct 19, 2023 | Initial | $5,026,000 | No comparison | 1 | SEC filing |
| Jun 8, 2022 | Initial | $10,000,002 | No comparison | 1 | SEC filing |
| Mar 9, 2021 | Initial | $0 | No comparison | 18 | SEC filing |
| Apr 9, 2019 | Initial | $2,249,986 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $200K
- Form D file number
- 021-539685
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Aegis Capital Corp. | 000015007 |
Source: Form D, filed Mar 3, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Oz Adler | Executive |
| Amnon Ben Shay | Director |
| Amit Berger | Director |
| Alon Dayan | Director |
| Zohar Heiblum | Director |
| Moshe Revach | Director |
| Ascher Shmulewitz | Director, Executive |
| Itschak Shrem | Director, Executive |
| Liat Sidi | Director |
| Stephen Simes | Director |
| Eric So | Director |
| Yafit Stark | Director |
| Lior Vider | Director |
| Amitay Weiss | Director |
| Adi Zuloff Shani | Executive |
| Dr. Adi Zuloff Shani | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
20 Raul Wallenberg Street, Tower A
Tel Aviv, L3, 6971916
Phone: (+972) (3) 717-5777
Tel Aviv, L3, 6971916
Phone: (+972) (3) 717-5777